Search research articles
Contact Us
Filters
Showing results (111-120 of 137) with videos related to
Page
of 14
Sort By:
EJNMMI Research
|
August 20, 2025
Predictors of renal function decline in patients with gastroenteropancreatic neuroendocrine tumors undergoing [177Lu]Lu-DOTA-TATE therapy
Felix L Herr, Christian Dascalescu, Victoria Fusch, et al.
European Radiology
|
August 20, 2022
Attitudes and perceptions of radiologists towards online (virtual) oncologic multidisciplinary team meetings during the COVID-19 pandemic-a survey of the European Society of Oncologic Imaging (ESOI)
Nathania Bonanno, Dania Cioni, Damiano Caruso, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine
|
March 27, 2025
PET- and CT-Based Imaging Criteria for Response Assessment of Gastroenteropancreatic Neuroendocrine Tumors Under Radiopharmaceutical Therapy
Felix L Herr, Christian Dascalescu, Matthias P Fabritius, et al.
Plos One
|
February 11, 2015
Correlation of perfusion MRI and 18F-FDG PET imaging biomarkers for monitoring regorafenib therapy in experimental colon carcinomas with immunohistochemical validation
Ralf S Eschbach, Wolfgang P Fendler, Philipp M Kazmierczak, et al.
European Radiology
|
March 25, 2023
Validation of the SSTR-RADS 1.0 for the structured interpretation of SSTR-PET/CT and treatment planning in neuroendocrine tumor (NET) patients
Freba Grawe, Ricarda Ebner, Thomas Geyer, et al.
European Journal of Nuclear Medicine and Molecular Imaging
|
January 18, 2024
[<sup>68 </sup>Ga]Ga-FAPI-46 PET/CT for locoregional lymph node staging in urothelial carcinoma of the bladder prior to cystectomy: initial experiences from a pilot analysis
Lena M Unterrainer, Lennert Eismann, Simon Lindner, et al.
European Radiology
|
August 25, 2023
Reliability and practicability of PSMA-RADS 1.0 for structured reporting of PSMA-PET/CT scans in prostate cancer patients
Freba Grawe, Franziska Blom, Michael Winkelmann, et al.
European Journal of Nuclear Medicine and Molecular Imaging
|
May 18, 2024
[<sup>68</sup>Ga]Ga-FAPI-46 PET/CT for penile cancer - a feasibility study
Lennert Eismann, Stephan T Ledderose, Benazir Enzinger, et al.
European Journal of Nuclear Medicine and Molecular Imaging
|
October 28, 2021
<sup>68</sup>Ga-EMP-100 PET/CT-a novel ligand for visualizing c-MET expression in metastatic renal cell carcinoma-first in-human biodistribution and imaging results
Lena M Mittlmeier, Andrei Todica, Franz-Josef Gildehaus, et al.
European Journal of Nuclear Medicine and Molecular Imaging
|
November 23, 2025
Artificial intelligence for TNM staging in NSCLC: a critical appraisal of segmentation utility in [<sup>1</sup>⁸F]FDG PET/CT
Maurice M Heimer, Jakob Dexl, Johanna Ta, et al.
Page
of 14
Search research articles
Search
Showing results (111-120 of 137) with videos related to
Sort By:
Page
of 14
EJNMMI Research
|
August 20, 2025
Predictors of renal function decline in patients with gastroenteropancreatic neuroendocrine tumors undergoing [177Lu]Lu-DOTA-TATE therapy
Felix L Herr, Christian Dascalescu, Victoria Fusch, et al.
European Radiology
|
August 20, 2022
Attitudes and perceptions of radiologists towards online (virtual) oncologic multidisciplinary team meetings during the COVID-19 pandemic-a survey of the European Society of Oncologic Imaging (ESOI)
Nathania Bonanno, Dania Cioni, Damiano Caruso, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine
|
March 27, 2025
PET- and CT-Based Imaging Criteria for Response Assessment of Gastroenteropancreatic Neuroendocrine Tumors Under Radiopharmaceutical Therapy
Felix L Herr, Christian Dascalescu, Matthias P Fabritius, et al.
Plos One
|
February 11, 2015
Correlation of perfusion MRI and 18F-FDG PET imaging biomarkers for monitoring regorafenib therapy in experimental colon carcinomas with immunohistochemical validation
Ralf S Eschbach, Wolfgang P Fendler, Philipp M Kazmierczak, et al.
European Radiology
|
March 25, 2023
Validation of the SSTR-RADS 1.0 for the structured interpretation of SSTR-PET/CT and treatment planning in neuroendocrine tumor (NET) patients
Freba Grawe, Ricarda Ebner, Thomas Geyer, et al.
European Journal of Nuclear Medicine and Molecular Imaging
|
January 18, 2024
[<sup>68 </sup>Ga]Ga-FAPI-46 PET/CT for locoregional lymph node staging in urothelial carcinoma of the bladder prior to cystectomy: initial experiences from a pilot analysis
Lena M Unterrainer, Lennert Eismann, Simon Lindner, et al.
European Radiology
|
August 25, 2023
Reliability and practicability of PSMA-RADS 1.0 for structured reporting of PSMA-PET/CT scans in prostate cancer patients
Freba Grawe, Franziska Blom, Michael Winkelmann, et al.
European Journal of Nuclear Medicine and Molecular Imaging
|
May 18, 2024
[<sup>68</sup>Ga]Ga-FAPI-46 PET/CT for penile cancer - a feasibility study
Lennert Eismann, Stephan T Ledderose, Benazir Enzinger, et al.
European Journal of Nuclear Medicine and Molecular Imaging
|
October 28, 2021
<sup>68</sup>Ga-EMP-100 PET/CT-a novel ligand for visualizing c-MET expression in metastatic renal cell carcinoma-first in-human biodistribution and imaging results
Lena M Mittlmeier, Andrei Todica, Franz-Josef Gildehaus, et al.
European Journal of Nuclear Medicine and Molecular Imaging
|
November 23, 2025
Artificial intelligence for TNM staging in NSCLC: a critical appraisal of segmentation utility in [<sup>1</sup>⁸F]FDG PET/CT
Maurice M Heimer, Jakob Dexl, Johanna Ta, et al.
Page
of 14